BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ABSA International - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ABSA International
X-ORIGINAL-URL:https://absa.org
X-WR-CALDESC:Events for ABSA International
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250501T130000
DTEND;TZID=America/Chicago:20250501T140000
DTSTAMP:20260604T110710
CREATED:20250501T131943Z
LAST-MODIFIED:20250501T131943Z
UID:10000559-1746104400-1746108000@absa.org
SUMMARY:Too Shy to Ask the Listserv panel discussion
DESCRIPTION:On Thursday\, May 1\, 2025 MABioN is hosting another edition of our Too Shy to Ask the Listserv panel discussion. \nThe webinar will be from 1-2pm (Central Time)/ 2-3pm (Eastern) \nHave you ever had a biosafety question but you were too shy to post it on the ABSA listserv?  Well this webinar is for you.  Participants can submit questions and our panel of Biosafety Experts will be on hand to answer them.  All question submissions will be completely anonymous so feel free to ask any biosafety questions your heart desires.  Our panel will consist of biosafety professionals from across the country who have expertise in shipping\, training\, viral vectors\, select agents and more. \nSubmit your questions! \nRegistration at the link below is via our FourWaves event site. Once you register you will have access to the Zoom link directly on the event site. \n\nMABioN Members – Free (A coupon code will be emailed to current paid members)\nNon-Members – $10\n\nWe look forward to seeing you there! \nRegister here: \nhttps://event.fourwaves.com/tstal-may-2025/pages
URL:https://absa.org/event/too-shy-to-ask-the-listserv-panel-discussion/
LOCATION:Webinar
CATEGORIES:Affiliate
ATTACH;FMTTYPE=image/jpeg:https://absa.org/wp-content/uploads/2024/01/MABioN-848.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240118T120000
DTEND;TZID=America/Chicago:20240118T130000
DTSTAMP:20260604T110710
CREATED:20240111T200007Z
LAST-MODIFIED:20240111T200042Z
UID:10000343-1705579200-1705582800@absa.org
SUMMARY:FREE MABioN Webinar - Considerations for Working with LCMV - From Bench to Bedside
DESCRIPTION:Webinar summary: \nLymphocytic choriomeningitis virus (LCMV) is a single-stranded RNA arenavirus commonly used in laboratory animal models to examine acute and chronic viral infections and immunopathology. However\, there is wide variation in LCMV biosafety practices between institutions\, based on differing interpretations of guidelines and risk data. This lack of consensus can pose a challenge to the biosafety professional who may be evaluating LCMV use at their facility. The first part of this presentation will compare the two most common laboratory strains of LCMV\, demonstrate the variation in biosafety policy between institutions\, and discuss one institution’s recent approach to navigating the use of this virus. \nOutside of the laboratory\, LCMV has also become a promising viral vector with potential use in immunizations and immunotherapy. The second portion of this presentation will examine the applications of LCMV in a clinical setting\, discussing the biosafety practices necessary for the safe handling of LCMV-based human gene therapies\, focusing on the clinical risk assessment associated with recombinant forms of LCMV. Considerations for the safety of clinical subjects\, staff\, and close contacts will be explored.   Presented by Caitlyn Hauke\, PhD\, Clinical Biosafety Services Erik Pietrowicz\, Dartmouth College
URL:https://absa.org/event/free-mabion-webinar-considerations-for-working-with-lcmv-from-bench-to-bedside/
LOCATION:Zoom\, United States
CATEGORIES:Affiliate
ATTACH;FMTTYPE=image/jpeg:https://absa.org/wp-content/uploads/2024/01/MABioN-848.jpg
GEO:37.09024;-95.712891
END:VEVENT
END:VCALENDAR